Taltz is supplied as 80mg of ixekizumab per mL in a single-dose prefilled autoinjector or syringe. ... Taltz. Package insert. Eli Lilly and Company; 2022. Accessed August 8, 2022.

Ixekizumab has taken a major step toward its approval for the treatment of psoriatic arthritis and enthesitis-related arthritis in children, based on positive data from a phase 3 trial.

* Eli Lilly and Co - Lilly has filed a supplemental biologics license application with FDA for Taltz as a treatment of adult patients with active PSA ...